
Oral GLP-1 for Weight Loss
Weight loss treatments now come as a daily pill, no needles required. The Wegovy pill has become the first to receive UK approval. We will cover how well they work, when the UK gets them, and how to choose between them.
You can find more information about weight loss and available treatments below or start your assessment to find out which treatment is right for you

Weight loss treatments now come as a daily pill, no needles required. The Wegovy pill has become the first to receive UK approval. We will cover how well they work, when the UK gets them, and how to choose between them.

The Wegovy pill was UK- approved on 11 June 2026. Switching from Mounjaro means a short washout, less weight loss on average, and a proven heart benefit. Your routine will move from weekly to daily.

The Wegovy pill is now available for pre-order. Read on to save £30 on your first purchase!

Semaglutide should not survive your stomach. Salcaprozate sodium (SNAC) is the reason it does. It shields the drug from acid, helping it cross the stomach lining into your blood.

Oral Wegovy delivered 13.6% average weight loss over 64 weeks in the OASIS 4 trial. Around three in ten people lost 20% plus. Approved in the UK as of June 2026, with NHS review pending.

Getting started with Wegovy injections is easier than you may think. In this step-by-step guide we will cover everything you need to know, from your first dose of Wegovy, how to use your pen through full titration – including Wegovy HD 7.2 mg pens.

Foundayo (orforglipron) and the Wegovy pill are daily oral GLP-1 weight loss treatments. Foundayo fits more easily around meals and other medications. Oral Wegovy has strict rules around dosing.

Foundayo is a once-daily oral GLP-1 pill. How Foundayo works in the body to support weight loss is by keeping your brain’s fullness signals active for longer and slowing stomach emptying after meals.

Foundayo is a once-daily weight loss pill with no food or water restrictions. It became the first oral non-peptide GLP-1 approved in the US for weight management in April 2026. UK approval is pending.

Foundayo (orforglipron) is a once-daily weight loss pill. Available in six strengths, your Foundayo milligram dose builds up gradually over three to four months from 0.8 mg to long-term maintenance.